Radiation therapy in prostate cancer
This article was originally published in Clinica
Executive Summary
Treatment of early-stage prostate cancer with external beam radiation therapy (EBRT) carries a lower risk of subsequent impotency than nerve-sparing surgery, a new study shows. The findings, presented at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Florida this month, showed that EBRT for patients aged 50 to 69 years resulted in slightly lower impotency rates than nerve-sparing surgery in patients of the same age range.